| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/15/2005 | WO2005052148A3 Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates |
| 09/15/2005 | WO2005040428A3 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 09/15/2005 | WO2003000844A3 Protein modification and maintenance molecules |
| 09/15/2005 | US20050204424 for transgenic plants |
| 09/15/2005 | US20050204422 Using vector transformation to express antisense sequences which suppress phytoene desaturase activity and enhance phytoene concentration in plant |
| 09/15/2005 | US20050203283 ISOFORMS OF NUCLEAR RECEPTOR RXR a |
| 09/15/2005 | US20050203282 For screening of agonists and antagonists of receptor which may have advantageous pharmaceutical or diagnostical properties; for identification of patients who may present genetic disorders induced by inactive receptor |
| 09/15/2005 | US20050203026 Rosacea; vascular endothelial growth factor inhibitors; protease inhibitors such as Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor |
| 09/15/2005 | US20050203022 Type II TGF-beta receptor/immunoglobulin constant region fusion proteins |
| 09/15/2005 | US20050203012 Human parathyroid hormone modifications, preparation and use |
| 09/15/2005 | US20050203007 Eglin c based drugs for treatment of disease |
| 09/15/2005 | US20050202547 Allows the above microorganism to use cyclododecanol and cyclododecanone (12-membered ring compounds) as sole carbon source for growth and energy |
| 09/15/2005 | US20050202544 Nucleotide sequences coding benzoic/anthranilic acid regulatory sequences in tandem; gene transfer vector for improving heterologous gene expression |
| 09/15/2005 | US20050202543 Method for producing L-amino acid |
| 09/15/2005 | US20050202540 Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene |
| 09/15/2005 | US20050202539 System for screening eukaryotic membrane proteins |
| 09/15/2005 | US20050202535 Fusion protein comprising bowman-kirk, soybean trypsin and eglin C inhibitors for use in treatment and prevention of inflammatory, arthritic and skin disorders |
| 09/15/2005 | US20050202530 Enhanced secretion of a polypeptide by a microorganism |
| 09/15/2005 | US20050202527 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants |
| 09/15/2005 | US20050202520 Has a histidine tag and where the subdomain of the IMPDH polypeptide is modified so that the rate stability of the modified polypeptide is maintained relative to the wild-type IMPDH polypeptide |
| 09/15/2005 | US20050202519 Mutated abl kinase domains |
| 09/15/2005 | US20050202502 Oxaloacetate hydrolase deficient fungal host cells |
| 09/15/2005 | US20050202494 Catalases |
| 09/15/2005 | US20050202487 Methods for isolation of bacteria from biological samples |
| 09/15/2005 | US20050202481 Novel polypeptide ESDN, polynuleotides encoding the polypeptide, and utility of the polypeptide |
| 09/15/2005 | US20050202474 Phosphodiesterases |
| 09/15/2005 | US20050202462 Hepatic modulator for prevention and treatment of hepatic dysfunction, hepatitis and liver cancer |
| 09/15/2005 | US20050202453 Using rolling circle amplification (RCA) to replicate plasmid DNA, isolated from yeast , comprising heterologous gene sequences; gene expression analysis; DNA sequencing; yeast two-hybrid analysis |
| 09/15/2005 | US20050202452 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein |
| 09/15/2005 | US20050202437 Expression vector comprised of lactobacillus and heterologous gene sequences for use as gene therapeutic tools; enhancing expression of exogenous gene sequences |
| 09/15/2005 | US20050202426 Whole cell engineering using real-time metabolic flux analysis |
| 09/15/2005 | US20050202425 expression vector; host cell transformed with gene; culturing cell to produce polypeptide that has an activity of converting a sulfated fucogalactan into a smaller molecule |
| 09/15/2005 | US20050202424 Membrane protein for use as tool in identifying modulators for treatment of phenotype-mediated antibiotic-resistance; microbiocides; bactericides; preventing infection in cystic fibrosis patients |
| 09/15/2005 | US20050202148 Preparation of microbial oil |
| 09/15/2005 | US20050202048 Chlamydia antigens and vaccine uses of the protein |
| 09/15/2005 | US20050202042 Toxin B repeating units (rBRU) of Clostridium difficile and an antigen of a pathogenic microorganism other than C. difficile; eliciting T-cell dependent and antibody responses |
| 09/15/2005 | US20050202040 Methods for large scale productions of recombinant DNA-derived tPA or K2S molecules |
| 09/15/2005 | US20050202017 Assay; contacting a test compound with a HB-954 polypeptide; determining whether the test compound binds to the G protein-coupled receptor |
| 09/15/2005 | US20050202016 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins |
| 09/15/2005 | US20050201977 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 09/15/2005 | DE102004009161A1 Producing defined enzyme mixture and/or metabolite mixture for fermentation of target substrates, by inoculating microorganisms in solid-phase bioreactor with inducer substrates and keeping mixed culture under appropriate conditions |
| 09/15/2005 | CA2598687A1 Flavonoids |
| 09/15/2005 | CA2563397A1 Adzymes and uses thereof |
| 09/15/2005 | CA2558960A1 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 09/15/2005 | CA2558593A1 .beta.-fructofuranosidase variants |
| 09/15/2005 | CA2557819A1 Magnetic device for isolation of cells and biomolecules in a microfluidic environment |
| 09/15/2005 | CA2553734A1 Rna-dependent dna polymerase from geobacillus stearothermophilus |
| 09/14/2005 | EP1574583A1 Methods for isolation of bacteria from biological samples |
| 09/14/2005 | EP1574579A2 Outer surface proteins, their genes, and their use |
| 09/14/2005 | EP1574578A1 Monomeric protein of the TGF-beta family |
| 09/14/2005 | EP1574577A2 Growth differentiation factor-11 |
| 09/14/2005 | EP1574566A1 A microbial process for arginine production |
| 09/14/2005 | EP1574565A1 Method of selecting escherichia coli strain overexpressing foreign gene, escherichia coli mutant thus selected and process for producing enzyme and compound using the same |
| 09/14/2005 | EP1574564A1 Microorganism or cell collecting method, and microorganism or cell collecting implement used for the method |
| 09/14/2005 | EP1573060A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene |
| 09/14/2005 | EP1573028A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 09/14/2005 | EP1573013A2 Parallel chromosomal stacking of traits in bacteria |
| 09/14/2005 | EP1573007A2 Method for chromosomal engineering |
| 09/14/2005 | EP1572995A2 Novel proteins and nucleic acids encoding same |
| 09/14/2005 | EP1572990A2 Increasing carotenoid production in bacteria via chromosomal integration |
| 09/14/2005 | EP1572982A1 Microorganism producing 5 -xanthylic acid |
| 09/14/2005 | EP1572981A1 Mutations affecting plasmid copy number |
| 09/14/2005 | EP1572980A2 Methods for improving secondary metabolite production in fungi |
| 09/14/2005 | EP1572979A1 A method and apparatus for automatic staining of tissue samples |
| 09/14/2005 | EP1572978A2 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 09/14/2005 | EP1572977A2 Assay and compositions for detection of bacillus anthracis nucleic acid |
| 09/14/2005 | EP1572976A2 Modulating immune responses |
| 09/14/2005 | EP1572974A2 Polynucleotide sequence detection assays and analysis |
| 09/14/2005 | EP1572968A2 Lutzomyia longipalpis polypeptides and methods of use |
| 09/14/2005 | EP1572967A2 Il-1 receptor based antagonists and methods of making and using |
| 09/14/2005 | EP1572966A2 Complete biosynthetic gene set for synthesis of polyketide antibiotics, including the albicidin family, resistance genes and uses thereof |
| 09/14/2005 | EP1572962A2 Bioinformatically detectable group of novel regulatory genes and uses thereof |
| 09/14/2005 | EP1572958A2 Biomimetic membranes |
| 09/14/2005 | EP1572953A2 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42 |
| 09/14/2005 | EP1572948A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/14/2005 | EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 09/14/2005 | EP1572938A2 Polyvalent cation-sensing receptor in atlantic salmon |
| 09/14/2005 | EP1572937A2 Motif-grafted hybrid polypeptides and uses thereof |
| 09/14/2005 | EP1572935A2 Methods of making hypermutable cells using pmsr homologs |
| 09/14/2005 | EP1572934A2 Follistatin domain containing proteins |
| 09/14/2005 | EP1572932A2 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 09/14/2005 | EP1572930A2 Albumin-fused kunitz domain peptides |
| 09/14/2005 | EP1572928A2 Plant acyl-coa synthetases |
| 09/14/2005 | EP1572922A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/14/2005 | EP1572910A2 Signal for packaging of influenza virus vectors |
| 09/14/2005 | EP1572909A2 A follistatin domain containing protein |
| 09/14/2005 | EP1572904A2 Modified bace |
| 09/14/2005 | EP1572898A2 Novel proteins and nucleic acids encoding same |
| 09/14/2005 | EP1572895A2 Methods for producing hyaluronan in a recombinant host cell |
| 09/14/2005 | EP1572891A2 Bone anti-resorptive compounds |
| 09/14/2005 | EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use |
| 09/14/2005 | EP1572889A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 09/14/2005 | EP1572888A2 Methods for generating, selecting, and identifying compounds which bind a target molecule |
| 09/14/2005 | EP1572887A2 Neural regeneration peptide and methods for their use in treatment of brain damage |
| 09/14/2005 | EP1572885A2 Methods for treating diabetes and other blood sugar disorders |
| 09/14/2005 | EP1572883A2 Human cytokine receptor |
| 09/14/2005 | EP1572881A2 Tacis and br3 polypeptides and uses thereof |
| 09/14/2005 | EP1572878A2 Compositions and methods for inferring a response to a statin |
| 09/14/2005 | EP1572877A2 Drug metabolizing enzymes |
| 09/14/2005 | EP1572876A2 Transcriptional regulation of target genes |